Armani 15% stake sale draws luxury beauty

Giorgio Armani's death in September 2025 has triggered a mandatory 15% stake sale in the Armani Group, with a deadline set for March 2027. The founder's will instructs his heirs to sell approximately 15% of the privately held company within 12 to 18 months of his passing, creating a pivotal moment for luxury beauty investors.

Armani Group CEO Giuseppe Marsocci, speaking on the sidelines of a Milan fashion show, confirmed the company intends to follow the founder's timetable. He stated that no decision has been made but that the group plans to respect the schedule. "It is not written in stone that it has to be one investor," Marsocci told reporters. A deal would depend on reaching agreement on price and details.

Preferred buyers and negotiation dynamics

Giorgio Armani named L'Oréal, LVMH, and EssilorLuxottica as preferred buyers in his will. The Armani Group is poised to hold meetings with all three companies in the coming weeks to discuss the initial 15% stake sale. The founder had previously considered dividing the stake equally, giving each a 5% holding. An unnamed person close to the situation described the dynamic, saying no one wants to jump on the opportunity but no one wants to let it pass, so everyone gets to be around the table.

The will also gives priority to these three groups for the stake sale. People close to EssilorLuxottica have indicated limited appetite for a large stake, while LVMH has expressed interest though some have questioned how Armani's broad business would fit its portfolio. Prada has ruled out a bid while it focuses on its Versace turnaround.

L'Oréal's strategic interest and partnership history

L'Oréal holds a long-standing beauty licensing partnership with Armani, a relationship that began in 1988. The partnership, renewed in 2018 and extended to 2050, developed lines of make-up, skin care, and fragrance. People close to L'Oréal regard protecting this licence as a priority.

L'Oréal CFO Christophe Babule addressed the potential investment during a Capital Markets Day event in December 2025. "We are quite honoured by the consideration of the heirs of the family towards their willingness to see L'Oréal investing in their company," Babule said. He added that this is the kind of opportunity a leader in luxury beauty must evaluate, though he could not disclose more details at the time.

Valuation challenges and market context

Agreeing on a price presents a significant challenge. Armani suggested a valuation of about €10 billion, while potential investors have valued the company between €3 billion and €7 billion. Weak luxury market conditions reportedly slowed preparations for the ownership transition and could potentially delay the deadline beyond March 2027.

The Armani Group's latest financial results show a 2.8% decline in sales to €2.192 billion in 2025. The company attributed this to a focus on stability and managerial solidity amid geopolitical turmoil and sector-wide structural challenges.

Beyond the initial 15%, the will calls for the heirs to dispose of a further 30% to 54.9% of the business over the next three to five years, with a stock-market listing as an alternative. In a separate managerial shift, Dario Vitale took charge of Emporio Armani and Giorgio Armani Accessories this month, becoming the first person not part of the Armani family to lead one of its lines. EssilorLuxottica’s eyewear agreement with Armani runs until 2038.

Armani Group's upcoming meetings with LVMH, L'Oréal and EssilorLuxottica are scheduled for the coming weeks.